In summary, in this retrospective cohort study we extend the findings of our previous work, confirming that in a real-world setting of an outpatient academic endocrine practice, GLP-1 analogs may be particularly well suited in mediating weight loss in obese, diabetic patients on psychotropic medications and specifically in patients on second-generation APMs and/or ADMs, particularly patients on SSRIs
[DOI] [PMC free article] [PubMed] [Google Scholar] 30.McMurray J.J.V., Solomon S.D., Inzucchi S.E., Kber L., Kosiborod M.N., Martinez F.A., Ponikowski P., Sabatine M.S., Anand I.S., Blohlvek J., et al
40: 42854291 (2022) Moscovitz JE, Herrera-Garcia G, Guo GL, Aleksunes LM
Once you have covered the needle, push the cap entirely on